Search results
Daphne Koller speaking about transforming drug development at AWS re:Invent 2019 The separation was due largely to limitations in biological data — while access to large, rich data sets has driven the success of machine learning, such data sets are still rare in biology where data generation remains largely artisanal. By enabling the ...
Oct 9, 2023 · Daphne Koller. CEO and founder, insitro. Age: 55. Education: Postdoc, Computer Science, UC Berkeley; PhD, Computer Science, Stanford University; M.S., Computer Science and B.S., Mathematics...
Our Founding Vision. A Letter From Daphne Koller. While many of us have witnessed the incredible medical advances transforming our ability to treat and even cure patients, drug discovery and development is getting harder and more expensive, leaving many patients without effective therapies.
